Cargando…

Cytokine storm syndrome in severe COVID-19

Detalles Bibliográficos
Autores principales:	Ruscitti, Piero, Berardicurti, Onorina, Iagnocco, Annamaria, Giacomelli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252135/ https://www.ncbi.nlm.nih.gov/pubmed/32376400 http://dx.doi.org/10.1016/j.autrev.2020.102562

Ejemplares similares

Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
por: Ruscitti, Piero, et al.
Publicado: (2020)

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences
por: Ruscitti, Piero, et al.
Publicado: (2020)

Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome?
por: Ciaffi, Jacopo, et al.
Publicado: (2021)

Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities
por: Ruscitti, Piero, et al.
Publicado: (2018)

Association Between Minor Salivary Gland Biopsy During Sjӧgren’s Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis
por: Berardicurti, Onorina, et al.
Publicado: (2021)

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
por: Ruscitti, Piero, et al.
Publicado: (2017)

The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)

Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
por: Ruscitti, Piero, et al.
Publicado: (2020)

Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature
por: Ruscitti, Piero, et al.
Publicado: (2015)

Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021)

Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis
por: Cipriani, Paola, et al.
Publicado: (2016)

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts
por: Cipriani, Paola, et al.
Publicado: (2015)

Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis
por: Palumbo, Pierpaolo, et al.
Publicado: (2022)

Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis
por: Cipriani, Paola, et al.
Publicado: (2014)

CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
por: Carubbi, Francesco, et al.
Publicado: (2013)

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts
por: Liakouli, Vasiliki, et al.
Publicado: (2019)

IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018)

COVID-19: In the Eye of the Cytokine Storm
por: de la Rica, Roberto, et al.
Publicado: (2020)

COVID-19: consider cytokine storm syndromes and immunosuppression
por: Mehta, Puja, et al.
Publicado: (2020)

The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the “hyperferritinemic syndromes”
por: Berardicurti, Onorina, et al.
Publicado: (2023)

Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
por: Kalinina, Olga, et al.
Publicado: (2022)

The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
por: Navarini, Luca, et al.
Publicado: (2023)

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers
por: Ruscitti, Piero, et al.
Publicado: (2016)

Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19
por: Hegyi, Péter, et al.
Publicado: (2020)

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
por: Ruscitti, Piero, et al.
Publicado: (2022)

Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
por: Castelli, Vanessa, et al.
Publicado: (2020)

Cytokine Storms: Understanding COVID-19
por: Mangalmurti, Nilam, et al.
Publicado: (2020)

Nicotine, cytokine storms and COVID-19
por: Boland, Xavier, et al.
Publicado: (2021)

A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome
por: Reiff, Daniel D., et al.
Publicado: (2022)

Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020)

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
por: Remy, Kenneth E., et al.
Publicado: (2020)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

COVID-19 cytokine storm syndrome: a threshold concept
por: Chen, Luke Y C, et al.
Publicado: (2021)

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
por: Navarini, Luca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0lc9ngq4ul8o4glhg02qtnbn0p